2.Brown, B, et al. Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. Journal of Virology 2003; 77: 8973–8984.
3.Wolthers, KC, et al. Human parechoviruses as an important viral cause of sepsis-like illness and meningitis in young children. Clinical Infectious Diseases 2008; 47: 358–363.
4.Zoll, J, et al. Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathogens 2009; 5: e1000416.
5.Holtz, LR, et al. Klassevirus 1, a previously undescribed member of the family Picornaviridae, is globally widespread. Virology Journal 2009; 6: 86.
6.Kapoor, A, et al. A highly prevalent and genetically diversified Picornaviridae genus in South Asian children. Proceedings of the National Academy of Sciences USA 2008; 105: 20482–20487.
7.Holtz, LR, et al. Identification of a novel picornavirus related to cosaviruses in a child with acute diarrhea. Virology Journal 2008; 5: 159.
8.Li, L, et al. A novel picornavirus associated with gastroenteritis. Journal of Virology 2009; 83: 12002–12006.
9.Muir, P, et al. Molecular typing of enteroviruses: current status and future requirements. The European Union concerted action on virus meningitis and encephalitis. Clinical Microbiology Reviews 1998; 11: 202–227.
10.McMinn, PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiology Reviews 2002; 26: 91–107.
11.Chua, BH, et al. The molecular basis of mouse adaptation by human enterovirus 71. Journal of General Virology 2008; 89: 1622–1632.
12.Chan, YF, Sam, IC, AbuBakar, S. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infection, Genetics and Evolution 2009 (in press).
13.Van der, Sanden S, et al. , on behalf of the Dutch Working Group for Clinical Virology. Epidemiology of enterovirus 71 in the Netherlands, 1963–2008. Journal of Clinical Microbiology 2009; 47: 2826–2833.
14.Cuervo, NS, et al. Genomic features of intertypic recombinant Sabin poliovirus strains excreted by primary vaccinees. Journal of Virology 2001; 75: 5740–5751.
15.Lukashev, AN. Role of recombination in evolution of enteroviruses. Reviews in Medical Virology 2005; 15: 157–167.
16.Santti, J, et al. Evidence of recombination among enteroviruses. Journal of Virology 1999; 73: 8741–8749.
17.Oprisan, G, et al. Natural genetic recombination between co-circulating heterotypic enteroviruses. Journal of General Virology 2002; 83: 2193–2200.
18.Lukashev, AN, et al. Recombination in circulating enteroviruses. Journal of Virology 2003; 77: 10423–10431.
19.Oberste, MS, Peñaranda, S, Pallansch, MA. RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses. Journal of Virology 2004; 78: 2948–2955.
20.Simmonds, P, Welch, J. Frequency and dynamics of recombination within different species of human enteroviruses. Journal of Virology 2006; 80: 483–493.
21.Chan, YF, AbuBaker, S. Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerging Infectious Diseases 2004; 10: 1468–1470.
22.Ding, NZ, et al. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Research 2009; 145: 157–161.
23.Lin, YW, et al. Enterovirus 71 infection of human dendritic cells. Experimental Biology and Medicine (Maywood) 2009; 234: 1166–1173.
24.Nishimura, Y, et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nature Medicine 2009; 15: 794–797.
25.Yamayoshi, S, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nature Medicine 2009; 15: 798–801.
26.Moore, KL. Structure and function of P-selectin glycoprotein ligand-1. Leukemia and Lymphoma 1998; 29: 1–15.
27.Mulcahy, JV, Riddell, DR, Owen, JS. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux. Biochemical Journal 2004; 377: 741–747.
28.Webb, NR, et al. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. Journal of Biological Chemistry 1998; 273: 15241–15248.
29.Thilakawardhana, S, et al. Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction. Neurobiology of Aging 2005; 26: 813–823.
30.Eckhardt, ER, et al. High density lipoprotein endocytosis by scavenger receptor SR-BII is clathrin-dependent and requires a carboxyl-terminal dileucine motif. Journal of Biological Chemistry 2006; 281: 4348–4353.
31.Brodeur, MR, et al. Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3. Journal of Bone and Mineral Research 2008; 23: 326–337.
32.Grove, J, et al. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. Journal of Virology 2007; 81: 3162–3169.
33.Barth, H, et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. Journal of Virology 2008; 82: 3466–3479.
34.Mueller, S, Wimmer, E, Cello, J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Research 2005; 111: 175–193.
35.Racaniello, VR. One hundred years of poliovirus pathogenesis. Virology 2006; 344: 9–16.
36.Wong, KT, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. Journal of Neuropathology and Experimental Neurology 2008; 67: 162–169.
37.Chen, CS, et al. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. Journal of Virology 2007; 81: 8996–9003.
38.Wen, YY, et al. Comparative study of enterovirus 71 infection of human cell lines. Journal of Medical Virology 2003; 70: 109–118.
39.Kuo, RL, et al. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. Journal of General Virology 2002; 83: 1367–1376.
40.Chan, YF, Abubakar, S. Enterovirus 71 infection induces apoptosis in Vero cells. Malaysian Journal of Pathology 2003; 25: 29–35.
41.Chang, SC, et al. Diverse apoptotic pathways in enterovirus 71-infected cells. Journal of Neurovirology 2004; 10: 338–349.
42.Liang, CC, et al. Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. Journal of Medical Virology 2004; 74: 597–603.
43.Chen, TC, et al. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cellular Microbiology 2007; 9: 2676–2688.
44.Huang, SC, et al. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. Journal of Medical Virology 2009; 81: 1241–1252.
45.Chan, LG, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clinical Infectious Diseases 2000; 31: 678–683.
46.Lum, LC, et al. Fatal enterovirus 71 encephalomyelitis. Journal of Pediatrics 1998; 133: 795–798.
47.Yang, Y, et al. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Human Pathology 2009; 40: 1288–1295.
48.Fu, YC, et al. Cardiac complications of enterovirus rhombencephalitis. Archives of Disease in Childhood 2004; 89: 368–373.
49.Shieh, WJ, et al. Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerging Infectious Diseases 2001; 7: 146–148.
50.Lin, YW, et al. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. Journal of Virology 2009; 83: 6477–6483.
51.Yang, KD, et al. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. Journal of Infectious Diseases 2001; 183: 850–856.
52.Chang, LY, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatric Research 2006; 60: 466–471.
53.Yu, CK, et al. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. Journal of Biomedical Science 2000; 7: 523–528.
54.Foo, DG, et al. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes and Infection 2007; 9: 1299–1306.
55.Wu, TC, et al. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. Journal of Virology 2007; 81: 10310–10315.
56.Chang, LY, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 2002; 109: e88.
57.Ho, M, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. New England Journal of Medicine 1999; 341: 929–935.
58.Luo, ST, et al. Enterovirus 71 maternal antibodies in infants, Taiwan. Emerging Infectious Diseases 2009; 15: 581–584.
59.Chiu, CH, et al. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes and Infection 2006; 8: 1671–1678.
60.Chang, LY, et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatric Infectious Disease Journal 1999; 18: 1092–1096.
61.Chong, CY, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatrica 2003; 92: 1163–1169.
62.Tai, WC, Hsieh, HJ, Wu, MT. Hand, foot and mouth disease in a healthy adult caused by intrafamilial transmission of enterovirus 71. British Journal of Dermatolology 2009; 160: 890–892.
63.Hamaguchi, T, et al. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. Emerging Infectious Diseases 2008; 14: 828–830.
64.Cardosa, MJ, et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerging Infectious Diseases 2003; 9: 461–468.
66.Chang, LY, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. Journal of the American Medical Association 2004; 291: 222–227.
67.Yang, TT, et al. Clinical features and factors of unfavorable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994–2003. Journal of Microbiology, Immunology, and Infection 2005; 38: 417–424.
68.Huang, CC, et al. Neurologic complications in children with enterovirus 71 infection. New England Journal of Medicine 1999; 341: 936–942.
69.Chang, LY, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. New England Journal of Medicine 2007; 356: 1226–1234.
70.Huang, MC, et al. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 2006; 118: e1785–1788.
71.Kao, SJ, et al. Mechanism of fulminant pulmonary edema caused by enterovirus 71. Clinical Infectious Diseases 2004; 38: 1784–1788.
72.Chang, LY, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354: 1682–1686.
73.Li, CC, et al. Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scandinavian Journal of Infectious Diseases 2002; 34: 104–109.
74.Yang, TT, et al. Clinical features and factors of unfavorable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994–2003. Journal of Microbiology, Immunology, and Infection 2005; 38: 417–424.
75.Hsia, SH, et al. Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. Pediatric Infectious Disease Journal 2005; 24: 331–334.
76.Iturriza-Gómara, M, Megson, B, Gray, J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. Journal of Medical Virology 2006; 78: 243–253.
77.Leitch, EC, et al. Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. Journal of Clinical Virology 2009; 44: 119–124.
78.Nix, WA, Oberste, MS, Pallansch, MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. Journal of Clinical Microbiology 2006; 44: 2698–2704.
79.Terletskaia-Ladwig, E, et al. A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. Journal of Medical Microbiology 2008; 57: 1000–1006.
80.Tsao, KC, et al. Responses of IgM for enterovirus 71 infection. Journal of Medical Virology 2002; 68: 574–580.
81.Blomberg, J, et al. New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet 1974; 2: 112.
82.Hagiwara, A, Tagaya, I, Yoneyama, T. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 1978; 9: 60–63.
83.Chumakov, M, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Archives of Virology 1979; 60: 329–340.
84.Nagy, G, et al. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Archives of Virology 1982; 71: 217–227.
85.Chang, LY, et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 2008; 122: 1271–1276.
86.Ho, HY, et al. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. Journal of General Virology 2008; 89: 2080–2089.
87.Le Jossec, M, et al. Genetic diversity patterns in the SR-BI/II locus can be explained by a recent selective sweep. Molecular Biology and Evolution 2004; 21: 760–769.
88.Mata, LJ, Urrutia, JJ, Lechtig, A. Infection and nutrition of children of a low socioeconomic rural community. American Journal of Clinical Nutrition 1971; 24: 249–259.
89.Beck, MA, Matthews, CC. Micronutrients and host resistance to viral infection. Proceedings of the Nutrition Society 2000; 59: 581–585.
90.Beck, MA, Williams-Toone, D, Levander, OA. Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency. Free Radical Biolology and Medicine 2003; 34: 1263–1270.
91.Cermelli, C, et al. Selenite inhibition of Coxsackie virus B5 replication: implications on the etiology of Keshan disease. Journal of Trace Elements in Medicine and Biology 2002; 16: 41–46.
92.Chan, KP, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerging Infectious Diseases 2003; 9: 78–85.
93.Ooi, MH, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clinical Infectious Diseases 2007; 44: 646–656.
95.Chung, PW, et al. Duration of enterovirus shedding in stool. Journal of Microbiology, Immunology, and Infection 2001; 34: 167–170.
96.Tosato, G, Rocchi, G, Archetti, I. Epidemiological study of a ‘hand-foot-and-mouth disease’ outbreak observed in Rome in the fall of 1973. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 1975; 230: 415–421.
97.Wang, JR, et al. An outbreak of enterovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis. Journal of Clinical Virology 2000; 17: 91–99.
98.Ooi, MH, et al. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. Journal of Clinical Microbiology 2007; 45: 1858–1866.
99.Kuramitsu, M, et al. Non-polio enterovirus isolation among families in Ulaanbaatar and Tov province, Mongolia: prevalence, intrafamilial spread, and risk factors for infection. Epidemiology and Infection 2005; 133: 1131–1142.
100.Welch, JB, et al. Detection of enterovirus viraemia in blood donors. Vox Sanguinis 2001; 80: 211–215.
101.Donoso Mantke, O, et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. Journal of Heart and Lung Transplantation 2005; 24: 1632–1638.
102.Chow, KC, et al. Congenital enterovirus 71 infection: a case study with virology and immunohistochemistry. Clinical Infectious Diseases 2000; 31: 509–512.
103.Nishikii, Y, et al. Favorable outcome in a case of perinatal enterovirus 71 infection. Pediatric Infectious Disease Journal 2002; 21: 886–887.
104.Hsu, BM, Chen, CH, Wan, MT. Prevalence of enteroviruses in hot spring recreation areas of Taiwan. FEMS Immunology and Medical Microbiology 2008; 52: 253–259.
105.Chen, CH, Hsu, BM, Wan, MT. Molecular detection and prevalence of enterovirus within environmental water in Taiwan. Journal of Applied Microbiology 2008; 104: 817–823.
106.Faustini, A, et al. An outbreak of aseptic meningitis due to echovirus 30 associated with attending school and swimming in pools. International Journal of Infectious Diseases 2006; 10: 291–297.
107.Centers for Disease Control and Prevention (CDC). Aseptic meningitis outbreak associated with echovirus 9 among recreational vehicle campers – Connecticut, 2003. Morbidity and Mortality Weekly Report 2004; 53: 710–713.
108.Hauri, AM, et al. An outbreak of viral meningitis associated with a public swimming pond. Epidemiology and Infection 2005; 133: 291–298.
109.Amvrosieva, TV, et al. Enteroviral infection outbreak in the Republic of Belarus: principal characteristics and phylogenetic analysis of etiological agents. Central European Journal of Public Health 2006; 14: 67–73.
110.Lee, SH, Kim, SJ. Detection of infectious enteroviruses and adenoviruses in tap water in urban areas in Korea. Water Research 2002; 36: 248–256.
111.Vivier, JC, Ehlers, MM, Grabow, WO. Detection of enteroviruses in treated drinking water. Water Research 2004; 38: 2699–2705.
112.Ehlers, MM, Grabow, WO, Pavlov, DN. Detection of enteroviruses in untreated and treated drinking water supplies in South Africa. Water Research 2005; 39: 2253–2258.
113.Croci, L, et al. Determination of enteroviruses, hepatitis A virus, bacteriophages and Escherichia coli in Adriatic Sea mussels. Journal of Applied Microbiology 2000; 88: 293–298.
114.Beuret, C, Baumgartner, A, Schluep, J. Virus-contaminated oysters: a three-month monitoring of oysters imported to Switzerland. Applied and Environmental Microbiology 2003; 69: 2292–2297.
115.Dubois, E, et al. Diversity of enterovirus sequences detected in oysters by RT-heminested PCR. International Journal of Food Microbiology 2004; 92: 35–43.
116.Gabrieli, R, et al. Enteric viruses in molluscan shellfish. New Microbiologica 2007; 30: 471–475.
117.Le Guyader, FS, et al. Aichi virus, norovirus, astrovirus, enterovirus, and rotavirus involved in clinical cases from a French oyster-related gastroenteritis outbreak. Journal of Clinical Microbiology 2008; 46: 4011–4017.
118.Ambert-Balay, K, et al. Prevalence and genetic diversity of Aichi virus strains in stool samples from community and hospitalized patients. Journal of Clinical Microbiology 2008; 46: 1252–1258.
119.Goyer, M, et al. Seroprevalence distribution of Aichi virus among a French population in 2006–2007. Archives of Virology 2008; 153: 1171–1174.
120.Saoji, VA. Hand, foot and mouth disease in Nagpur. Indian Journal of Dermatolology, Venereology and Leprology 2008; 74: 133–135.
122.Centre for Health Protection, Department of Health, Hong Kong. Guidelines on prevention of communicable diseases in schools/kindergartens/kindergartens-cum-child care centres/child care centres (revised January 2009) (http://www.chp.gov.hk/files/pdf/School_full_eng_20090115.pdf). Accessed 28 July 2009.
123.Wang, JR, et al. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. Journal of Clinical Microbiology 2002; 40: 10–15.
124.Podin, Y, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health 2006; 6: 180.
125.Huang, SC, et al. Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Research 2008; 131: 250–259.
126.Chan, YF, AbuBakar, S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiology 2006; 6: 74.
127.Shih, SR, et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Research 2000; 68: 127–136.
128.Li, ML, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 2002; 293: 386–395.
129.Hagiwara, A, Yoneyama, T, Takami, S, Hashimoto, I. Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease. Archives of Virology 1984; 79: 273–283.
130.Pérez-Vélez, CM, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clinical Infectious Diseases 2007; 45: 950–957.
131.Smith, TJ, et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 1986; 233: 1286–1293.
132.Shia, KS, et al. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. Journal of Medicinal Chemistry 2002; 45: 1644–1655.
133.Nolan, MA, et al. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 2003; 60: 1651–1656.
134.Prager, P, et al. Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors. Pediatric Critical Care Medicine 2003; 4: 377–381.
135.Li, ZH, et al. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. Journal of Infectious Diseases 2008; 197: 854–857.
136.Liu, ML, et al. Type I interferons protect mice against enterovirus 71 infection. Journal of General Virology 2005; 86: 3263–3269.
137.McKinney, RE Jr., Katz, SL, Wilfert, CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Reviews of Infectious Diseases 1987; 9: 334–356.
138.Cheng, MF, et al. Clinical application of reverse-transcription polymerase chain reaction and intravenous immunoglobulin for enterovirus encephalitis. Japanese Journal of Infectious Diseases 2008; 61: 18–24.
139.Moschovi, MA, et al. Enteroviral infections in children with malignant disease: a 5-year study in a single institution. Journal of Infection 2007; 54: 387–392.
140.Jantausch, BA, et al. Maternal plasma transfusion in the treatment of disseminated neonatal echovirus 11 infection. Pediatric Infectious Disease Journal 1995; 14: 154–155.
141.Wang, SM, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clinical Infectious Diseases 1999; 29: 184–190.
142.Frange, P, et al. Enterovirus 71 meningoencephalitis during chemotherapy in a child with metastatic osteosarcoma. Journal of Pediatric Hematology Oncology 2007; 29: 566–568.
143.Wang, SM, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. Journal of Clinical Virology 2006; 37: 47–52.
144.Galama, JM, et al. Antibodies against enteroviruses in intravenous Ig preparations: great variation in titres and poor correlation with the incidence of circulating serotypes. Journal of Medical Virology 1997; 53: 273–276.
145.Wang, SM, et al. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatric Pulmonology 2005; 39: 219–223.
146.Wang, JN, et al. Critical management in patients with severe enterovirus 71 infection. Pediatrics International 2006; 48: 250–256.
147.Wu, CN, et al. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001; 20: 895–904.
148.Chen, HF, et al. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006; 24: 2944–2951.
149.Tung, WS, et al. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genetic Vaccines and Therapy 2007; 5: 6.
150.Chung, YC, et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008; 26: 1855–1862.
151.Chen, HL, et al. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 2008; 26: 2882–2889.
152.Arita, M, et al. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. Journal of Virology 2007; 81: 9386–9395.
153.Mizuta, K, et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 2009; 27: 3153–3158.
154.Lin, TY, Chu, C, Chiu, CH. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. Journal of Infectious Diseases 2002; 186: 1161–1164.
155.Weng, TY, et al. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Research 2005; 67: 31–37.
156.Chen, HL, et al. Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine 2008; 26: 891–898.
157.Keswick, BH, Gerba, CP, Goyal, SM. Occurrence of enteroviruses in community swimming pools. American Journal of Public Health 1981; 71: 1026–1030.
158.Begier, EM, et al. An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico. Clinical Infectious Diseases 2008; 47: 616–623.
159.Chan, YF, AbuBakar, S. Virucidal activity of Virkon S on human enterovirus. Medical Journal of Malaysia 2005; 60: 246–248.
160.Abad, FX, Pintó, RM, Bosch, A. Disinfection of human enteric viruses on fomites. FEMS Microbiology Letters 1997; 156: 107–111.
161.Chambon, M, et al. Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein. Applied and Environmental Microbiology 2004; 70: 1717–1722.
162.Zoni, R, et al. Investigation on virucidal activity of chlorine dioxide. experimental data on feline calicivirus, HAV and Coxsackie B5. Journal of Preventive Medicine and Hygiene 2007; 48: 91–95.
163.Kawana, R, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 1997; 195 (Suppl. 2): 29–35.
164.Kampf, G, Kramer, A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clinical Microbiology Reviews 2004; 17: 863–893.
165.Wutzler, P, Sauerbrei, A. Virucidal efficacy of a combination of 0·2% peracetic acid and 80% (v/v) ethanol (PAA-ethanol) as a potential hand disinfectant. Journal of Hospital Infection 2000; 46: 304–308.
166.Kramer, A, et al. Virucidal activity of a new hand disinfectant with reduced ethanol content: comparison with other alcohol-based formulations. Journal of Hospital Infection 2006; 62: 98–106.
167.Macinga, DR, Sattar, SA, Jaykus, LA, Arbogast, JW. Improved inactivation of nonenveloped enteric viruses and their surrogates by a novel alcohol-based hand sanitizer. Applied and Environmental Microbiology 2008; 74: 5047–5052.
169.Kao, RY, et al. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chemistry and Biology 2004; 11: 1293–1299.
170.Herrero, LJ, et al. Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997–2000. Archives of Virology 2003; 148: 1369–1385.
171.Chua, KB, et al. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malaysian Journal of Pathology 2007; 29: 69–78.
172.Abubakar, S, et al. Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997. Scandinavian Journal of Infectious Diseases 1999; 31: 331–335.
173.Liu, CC, et al. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. Journal of Clinical Virology 2000; 17: 23–30.
174.Chen, KT, et al. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998–2005. Pediatrics 2007; 120: e244–252.
175.Sanders, SA, et al. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Archives of Virology 2006; 151: 1003–1013.
176.McMinn, P, Stratov, I, Nagarajan, L, Davis, S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clinical Infectious Diseases 2001; 32: 236–242.
177.AbuBakar, S, et al. Enterovirus 71 outbreak, Brunei. Emerging Infectious Diseases 2009; 15: 79–82.
179.Yang, F, et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. Journal of Clinical Microbiology 2009; 47: 2351–2352.
181.Li, L, et al. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. Journal of Clinical Microbiology 2005; 43: 3835–3839.
182.Lin, KH, et al. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. Journal of Medical Virology 2006; 78: 254–262.
183.Hosoya, M, et al. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatric Infectious Disease Journal 2006; 25: 691–694.
184.Tu, PV, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerging Infectious Diseases 2007; 13: 1733–1741.
185.Huang, YP, et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Research 2008; 137: 206–212.
186.Ang, LW, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001–2007. Annals of the Academy of Medicine Singapore 2009; 38: 106–112.